200 related articles for article (PubMed ID: 11606797)
21. Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment.
Gulezian D; Jacobson-Kram D; McCullough CB; Olson H; Recio L; Robinson D; Storer R; Tennant R; Ward JM; Neumann DA
Toxicol Pathol; 2000; 28(3):482-99. PubMed ID: 10862569
[TBL] [Abstract][Full Text] [Related]
22. p53 induction as a genotoxic test for twenty-five chemicals undergoing in vivo carcinogenicity testing.
Duerksen-Hughes PJ; Yang J; Ozcan O
Environ Health Perspect; 1999 Oct; 107(10):805-12. PubMed ID: 10504146
[TBL] [Abstract][Full Text] [Related]
23. The Syrian hamster embryo cells transformation assay identifies efficiently nongenotoxic carcinogens, and can contribute to alternative, integrated testing strategies.
Benigni R; Bossa C; Tcheremenskaia O; Battistelli CL; Giuliani A
Mutat Res Genet Toxicol Environ Mutagen; 2015 Feb; 779():35-8. PubMed ID: 25813724
[TBL] [Abstract][Full Text] [Related]
24. The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals.
LeBoeuf RA; Kerckaert GA; Aardema MJ; Gibson DP; Brauninger R; Isfort RJ
Mutat Res; 1996 Sep; 356(1):85-127. PubMed ID: 8841476
[TBL] [Abstract][Full Text] [Related]
25. Application of genetically altered models as replacement for the lifetime mouse bioassay in pharmaceutical development.
Alden C; Smith P; Morton D
Toxicol Pathol; 2002; 30(1):135-8. PubMed ID: 11890466
[TBL] [Abstract][Full Text] [Related]
26. Use of DNA repair-deficient XPA transgenic mice in short-term carcinogenicity testing.
van Steeg H; Klein H; Beems RB; van Kreijl CF
Toxicol Pathol; 1998; 26(6):742-9. PubMed ID: 9864090
[TBL] [Abstract][Full Text] [Related]
27. Evaluation on carcinogenicity of chemicals using transgenic mice.
Mitsumori K
Toxicology; 2002 Dec; 181-182():241-4. PubMed ID: 12505318
[TBL] [Abstract][Full Text] [Related]
28. Expectations for transgenic rodent cancer bioassay models.
Ashby J
Toxicol Pathol; 2001; 29 Suppl():177-82. PubMed ID: 11695555
[TBL] [Abstract][Full Text] [Related]
29. Regulatory Forum Opinion Piece*: Transgenic/Alternative Carcinogenicity Assays: A Retrospective Review of Studies Submitted to CDER/FDA 1997-2014.
Jacobs AC; Brown PC
Toxicol Pathol; 2015 Jul; 43(5):605-10. PubMed ID: 25630682
[TBL] [Abstract][Full Text] [Related]
30. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.
Flammang TJ; Tungeln LS; Kadlubar FF; Fu PP
Regul Toxicol Pharmacol; 1997 Oct; 26(2):230-40. PubMed ID: 9356286
[TBL] [Abstract][Full Text] [Related]
31. Assessing the predictiveness of the Syrian hamster embryo cell transformation assay for determining the rodent carcinogenic potential of single ring aromatic/nitroaromatic amine compounds.
Kerckaert GA; LeBoeuf RA; Isfort RJ
Toxicol Sci; 1998 Feb; 41(2):189-97. PubMed ID: 9520355
[TBL] [Abstract][Full Text] [Related]
32. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
33. Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet?
Benigni R
Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):407-17. PubMed ID: 22360376
[TBL] [Abstract][Full Text] [Related]
34. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and theEnvironment. Statement on ILSI/HESI research programme on alternative cancer models.
Blain PG
Toxicol Pathol; 2003; 31(2):254-7. PubMed ID: 12696588
[No Abstract] [Full Text] [Related]
35. Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays.
Kerckaert GA; Brauninger R; LeBoeuf RA; Isfort RJ
Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1075-84. PubMed ID: 8933057
[TBL] [Abstract][Full Text] [Related]
36. Deregulation of cancer-related pathways in primary hepatocytes derived from DNA repair-deficient Xpa-/-p53+/- mice upon exposure to benzo[a]pyrene.
van Kesteren PC; Zwart PE; Pennings JL; Gottschalk WH; Kleinjans JC; van Delft JH; van Steeg H; Luijten M
Toxicol Sci; 2011 Sep; 123(1):123-32. PubMed ID: 21715664
[TBL] [Abstract][Full Text] [Related]
37. In vitro cell transformation assays for an integrated, alternative assessment of carcinogenicity: a data-based analysis.
Benigni R; Bossa C; Tcheremenskaia O
Mutagenesis; 2013 Jan; 28(1):107-16. PubMed ID: 23132285
[TBL] [Abstract][Full Text] [Related]
38. The testing of chemicals in the Syrian hamster embryo (SHE) cell transformation assay for assessment of carcinogenic potential.
Engelhardt G; Schwind KR; Mussler B
Toxicol In Vitro; 2004 Apr; 18(2):213-8. PubMed ID: 14757112
[TBL] [Abstract][Full Text] [Related]
39. Morphological transformation of Syrian hamster embryo cells at pH 6.7 by bemitradine, a nongenotoxic carcinogen.
Oshiro Y; Balwierz PS; Morris DL; Alden CL; Bunch RT
In Vitr Mol Toxicol; 2001; 14(2):121-7. PubMed ID: 11690565
[TBL] [Abstract][Full Text] [Related]
40. ECVAM prevalidation study on in vitro cell transformation assays: general outline and conclusions of the study.
Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L; Vanparys P
Mutat Res; 2012 Apr; 744(1):12-9. PubMed ID: 22138617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
